Literature DB >> 34044906

Excess mortality and life-years lost in people with bipolar disorder: an 11-year population-based cohort study.

J K N Chan1, C S M Wong1, N C L Yung1, E Y H Chen1,2, W C Chang1,2.   

Abstract

AIMS: Bipolar disorder is associated with premature mortality, but evidence is mostly derived from Western countries. There has been no research evaluating shortened lifespan in bipolar disorder using life-years lost (LYLs), which is a recently developed mortality metric taking into account illness onset for life expectancy estimation. The current study aimed to examine the extent of premature mortality in bipolar disorder patients relative to the general population in Hong Kong (HK) in terms of standardised mortality ratio (SMR) and excess LYLs, and changes of mortality rate over time.
METHODS: This population-based cohort study investigated excess mortality in 12 556 bipolar disorder patients between 2008 and 2018, by estimating all-cause and cause-specific SMRs, and LYLs. Trends in annual SMRs over the 11-year study period were assessed. Study data were retrieved from a territory-wide medical-record database of HK public healthcare services.
RESULTS: Patients had higher all-cause [SMR: 2.60 (95% CI: 2.45-2.76)], natural-cause [SMR: 1.90 (95% CI: 1.76-2.05)] and unnatural-cause [SMR: 8.63 (95% CI: 7.34-10.03)] mortality rates than the general population. Respiratory diseases, cardiovascular diseases and cancers accounted for the majority of deaths. Men and women with bipolar disorder had 6.78 (95% CI: 6.00-7.84) years and 7.35 (95% CI: 6.75-8.06) years of excess LYLs, respectively. The overall mortality gap remained similar over time, albeit slightly improved in men with bipolar disorder.
CONCLUSIONS: Bipolar disorder is associated with increased premature mortality and substantially reduced lifespan in a predominantly Chinese population, with excess deaths mainly attributed to natural causes. Persistent mortality gap underscores an urgent need for targeted interventions to improve physical health of patients with bipolar disorder.

Entities:  

Keywords:  Bipolar disorder; excess life-years lost; mortality trend; premature mortality

Mesh:

Year:  2021        PMID: 34044906     DOI: 10.1017/S2045796021000305

Source DB:  PubMed          Journal:  Epidemiol Psychiatr Sci        ISSN: 2045-7960            Impact factor:   6.892


  5 in total

1.  Mortality, Revascularization, and Cardioprotective Pharmacotherapy After Acute Coronary Syndrome in Patients With Severe Mental Illness: A Systematic Review and Meta-analysis.

Authors:  Joe Kwun Nam Chan; Ryan Sai Ting Chu; Chun Hung; Jenny Wai Yiu Law; Corine Sau Man Wong; Wing Chung Chang
Journal:  Schizophr Bull       Date:  2022-09-01       Impact factor: 7.348

2.  The clinical characterization of the adult patient with bipolar disorder aimed at personalization of management.

Authors:  Roger S McIntyre; Martin Alda; Ross J Baldessarini; Michael Bauer; Michael Berk; Christoph U Correll; Andrea Fagiolini; Kostas Fountoulakis; Mark A Frye; Heinz Grunze; Lars V Kessing; David J Miklowitz; Gordon Parker; Robert M Post; Alan C Swann; Trisha Suppes; Eduard Vieta; Allan Young; Mario Maj
Journal:  World Psychiatry       Date:  2022-10       Impact factor: 79.683

3.  Comparison of years of life lost to 1,565 suicides versus 10,650 COVID-19 deaths in 2020 in Sweden: four times more years of life lost per suicide than per COVID-19 death.

Authors:  Rickard Ljung; Maria Grünewald; Anders Sundström; Lena Thunander Sundbom; Björn Zethelius
Journal:  Ups J Med Sci       Date:  2022-05-11       Impact factor: 2.646

4.  Prevalence and associated factors of obesity and overweight in Chinese patients with bipolar disorder.

Authors:  Wenying Yi; Haibo Wu; Ruikeng Li; Haijing Li; Zhen Song; Shenglin She; Yingjun Zheng
Journal:  Front Psychiatry       Date:  2022-09-06       Impact factor: 5.435

5.  The prevalence and associated clinical correlates of hyperuricemia in patients with bipolar disorder.

Authors:  Shuyun Li; Xiaobing Lu; Xiaodong Chen; Zebin Huang; Hui Zhou; Zezhi Li; Yuping Ning
Journal:  Front Neurosci       Date:  2022-09-16       Impact factor: 5.152

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.